Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/1999
05/27/1999CA2310228A1 Attaching substances to micro-organisms
05/27/1999CA2310215A1 Methods and compositions for the treatment of psoriasis
05/27/1999CA2309990A1 Modified antibodies with enhanced ability to elicit an anti-idiotype response
05/27/1999CA2309919A1 Treatment of hematologic disorders
05/27/1999CA2309885A1 Recombinant allergen with reduced enzymatic activity
05/27/1999CA2309826A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999CA2309761A1 Th2 cell depletion; compositions; methods
05/27/1999CA2309758A1 Reagents and methods useful for detecting diseases of the breast
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2309343A1 Toso
05/27/1999CA2309339A1 Transcriptionally regulated g protein-coupled receptor
05/26/1999EP0917879A2 Procédé amélioré pour la stabilisation des protéines
05/26/1999EP0917592A1 Attenuated respiratory syncytial virus
05/26/1999EP0917581A1 Fusion polypeptides com0prising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
05/26/1999EP0917577A2 Herpes simplex virus icp4 is an inhibitor of apoptosis
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917472A1 Antiprotozoal composition
05/26/1999EP0917471A2 Treatment and diagnosis of infections of gram positive cocci
05/26/1999EP0917468A1 Herbal formulation and therapeutic uses therefor
05/26/1999EP0917428A1 Hybrid matrix implants and explants
05/26/1999EP0678034B1 Inducing cytotoxic t lymphocyte responses
05/26/1999EP0635019B1 Opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
05/26/1999EP0616641B1 Humanized b-b10, an anti-il2 receptor antibody
05/26/1999EP0610290B1 Manufacture of a medicament for treatment of ocular inflammation by blockage of cell adhesion molecules
05/26/1999EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis
05/26/1999EP0453560B1 Localization and characterization of the wilms' tumor gene
05/26/1999CN1217751A Parapoxvirus vectors
05/26/1999CN1217750A Monoclonal antibody to CEA, Conjugates comprising said antibody, and their therapeutic use in ADEPT system
05/26/1999CN1217748A Transferrin receptor genes of moraxella
05/26/1999CN1217661A Method and composition for reconforming multi-epitopic antigens to initiate immune response
05/26/1999CN1217653A Functionalized nanotubes
05/26/1999CN1217632A Method of protein production using mitochondrial translation system
05/26/1999CN1217335A Method for preparing precursor medicine
05/26/1999CN1217212A Vaccine both for hepatitis A and measles and production method therefor
05/26/1999CN1217211A Immunity activating agent and preparation method therefor
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999US5906935 Cells transformed or transfected with HCMV US2-US5, US10-US11 genes
05/25/1999US5906826 Adminstering a biocompabilbe solid implant having the antigen releasably contained therein during a period when maternal antiboides are circulating in a mammal and are effective to stimulate active immunity
05/25/1999US5906821 Viral nucleotide sequences
05/25/1999US5906820 Epidermal growth factor receptor targeted molecules for treatment of inflammatory arthritis
05/25/1999CA1340555C Oral vaccines
05/20/1999WO1999024613A1 Human blood bacterium
05/20/1999WO1999024596A1 Expression plasmids for multiepitope nucleic acid-based vaccines
05/20/1999WO1999024579A1 Novel era
05/20/1999WO1999024578A2 Neisserial antigens
05/20/1999WO1999024577A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
05/20/1999WO1999024576A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999WO1999024571A2 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999WO1999024567A1 Tissue cement proteins from rhipicephalus appendiculatus
05/20/1999WO1999024566A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
05/20/1999WO1999024565A1 Methods and compositions for immunomodulation
05/20/1999WO1999024564A1 PRODUCTION OF NOVEL BOVINE RESPIRATORY SYNCYTIAL VIRUSES FROM cDNAs
05/20/1999WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
05/20/1999WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024467A1 IgG-BINDING PROTEIN FROM STAPHYLOCOCCUS AND NUCLEOTIDE SEQUENCE ENCODING THIS PROTEIN
05/20/1999WO1999024466A2 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
05/20/1999WO1999024463A2 Signal peptide-containing proteins
05/20/1999WO1999024077A2 Compositions and methods for targeted delivery of biologically-active factors
05/20/1999WO1999024068A1 Immortal avian cell line to grow avian and animal viruses to produce vaccines
05/20/1999WO1999024066A2 Methods and compositions for enhancing immune response and for the production of in vitro mabs
05/20/1999WO1999024065A1 COMPOUNDS INHIBITING CD4-gp120 INTERACTION AND USES THEREOF
05/20/1999WO1999024064A1 Antigen specific to meniere's disease and medical use thereof
05/20/1999WO1999024054A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999WO1999024049A1 Insect cells or fractions as adjuvant for antigens
05/20/1999WO1999024045A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999WO1999023879A1 Method for the augmentation of gene expression
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999015162A3 Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid a
05/20/1999WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
05/20/1999WO1999010475A3 Attenuated strains of mycobacteria
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999006557A3 Mammalian cell membrane proteins; related reagents
05/20/1999DE19750220A1 Producing polyoma virus-like particles in yeast for gene therapy, vaccine development and diagnosis
05/20/1999CA2671261A1 Neisserial antigens
05/20/1999CA2319380A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
05/20/1999CA2310575A1 Method for the augmentation of gene expression
05/20/1999CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999CA2309557A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
05/20/1999CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999CA2309344A1 Expression plasmids for multiepitope nucleic acid-based vaccines
05/20/1999CA2309335A1 Igg-binding protein from staphylococcus and nucleotide sequence encoding this protein
05/20/1999CA2309320A1 Glycosylated antibodies and antibody fragments having reactive ketone groups
05/20/1999CA2309206A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999CA2309007A1 Secreted proteins and polynucleotides encoding them
05/20/1999CA2308779A1 Human blood bacterium
05/20/1999CA2308606A1 Neisserial antigens
05/20/1999CA2305847A1 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
05/20/1999CA2305715A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999CA2276080A1 Antigen specific to meniere's disease and medical use thereof
05/19/1999EP0916730A2 FabH from Staphylococcus aureus
05/19/1999EP0916729A2 Novel reductase
05/19/1999EP0916728A1 Phenyl alanyl tRNA synthetase [EC 6.1.1.20] alpha subunit family, pheS (alpha), from Streptococcus pneumoniae
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916726A1 Attaching substances to micro-organisms
05/19/1999EP0916678A2 Method of clotting blood
05/19/1999EP0915980A2 Characterization of granulocytic ehrlichia and methods of use
05/19/1999EP0915979A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia
05/19/1999EP0915978A2 Dna immunization against chlamydia infection
1 ... 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 ... 1823